Form 4: CareDx Director Peter Maag Reports Acquisition of Shares and Stock Options

Director Peter Maag reports acquisition of CareDx shares and stock options in a recent SEC filing.

Summary

• Peter Maag, a director of CareDx, Inc., reported the acquisition of 10,570 shares of common stock on June 14, 2024.
• These shares were acquired at a price of $0.00 and are represented by restricted stock units vesting in one installment on June 14, 2025.
• Maag also acquired stock options for 16,048 shares with an exercise price of $9.3469 on the same date.
• These options vest monthly, starting July 14, 2024, through June 14, 2025.
• Following these transactions, Maag beneficially owns 337,834 shares of common stock and 16,048 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The acquisition of shares and options by a director could be seen as a positive signal, but it's not overwhelmingly so.

Positives

• The acquisition of shares and stock options by a director signals confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.

Stakeholder Impact

• The transactions may have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates